Supernus Pharmaceuticals

SUPNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.769 B

$47.64 +1.88%

Close of 7 Aug 2026

Revenue

$719.0M

#1727 by revenue

Earnings

-$38.6M

Loss-making

Shares outstanding

58,127,013

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#82Disc MedicineIRON$2.97B
#83ImmunomeIMNM$2.83B
#84Supernus PharmaceuticalsSUPN$2.77B
#85AtaiBeckleyATAI$2.67B
#86Nurix TherapeuticsNRIX$2.65B

Where these numbers come from

Share counts and financials for Supernus Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.